A biological classification of Huntington's disease: the Integrated Staging System

Overview of attention for article published in Lancet Neurology, July 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 17 news outlets
twitter: 49 X users
patent: 5 patents

facebook: 1 Facebook page
wikipedia: 2 Wikipedia pages
guideline: 1 clinical guideline source

Readers on

mendeley: 270 Mendeley

So far, Altmetric has seen 21 news stories from 17 outlets.

Can Biology Change How We Define Parkinson’s Disease?

Medscape, 05 Feb 2026

“Parkinson’s disease is the fastest-growing neurological disorder,” commented Daniela Berg, MD, president of the German…

Malattia di Huntington, l'interruzione di uno studio con tominersen, oligonucleotide antisenso, porta utili nozioni per reimpostare gli studi futuri

Pharmastar Italy, 17 Dec 2023

Neurologia e Psichiatria Malattia di Huntington, l'interruzione di uno studio con tominersen, oligonucleotide antisenso, porta…

El ensayo de fármaco antisentido proporciona información clave sobre la enfermedad de Huntington

Espanol.news, 07 Dec 2023

el detenido GENERACIÓN HD1 (GENHD1) del fármaco antisentido en investigación tominersen proporcionó información sobre la…

L’essai d’un médicament antisens fournit des informations clés sur la maladie de Huntington

Nouvelles du monde, 06 Dec 2023

L’arrêté GÉNÉRATION HD1 (GENHD1) sur le médicament antisens expérimental tominersen a fourni des informations sur le stade de…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 17 additional news stories.